Is Meridian Bioscience Inc (VIVO) a Bad Choice in Diagnostics & Research Thursday?
Thursday, January 19, 2023 03:54 PM | InvestorsObserver Analysts
Mentioned in this article
Meridian Bioscience Inc (VIVO) is near the top in its industry group according to InvestorsObserver. VIVO gets an overall rating of 68. That means it scores higher than 68 percent of stocks. Meridian Bioscience Inc gets a 92 rank in the Diagnostics & Research industry. Diagnostics & Research is number 64 out of 148 industries.
VIVO has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on VIVO!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 68 means the stock is more attractive than 68 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Meridian Bioscience Inc Stock Today?
Meridian Bioscience Inc (VIVO) stock is trading at $33.65 as of 3:53 PM on Thursday, Jan 19, a loss of -$0.04, or -0.12% from the previous closing price of $33.69. Volume today is below average. So far 131,091 shares have traded compared to average volume of 635,349 shares. The stock has traded between $33.65 and $33.76 so far today.
Click Here to get the full Stock Report for Meridian Bioscience Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
